Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has announcements × Filgrastim × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 32 Cisplatin 27 pembrolizumab 25 Paclitaxel 25 Pemetrexed 20 Nivolumab 18 Gemcitabine 18 Dexamethasone 15 Rituximab 14 Ipilimumab 12 Fluorouracil 11 Docetaxel 11 durvalumab 10 Cyclophosphamide 10 Lenalidomide 9 Bevacizumab 9 olaparib 8 atezolizumab 8 Cytarabine 8 Capecitabine 8 130-nm albumin-bound paclitaxel 8 daratumumab 7 Prednisone 7 Leucovorin 7 Etoposide 7 Doxorubicin 7 Bortezomib 7 venetoclax 6 osimertinib 6 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05722015 2025-09-11

MK-3475A-D77

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

377 enrolled 17 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡